Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 75,171 | N/A | N/A |
| Receivables | 151 | N/A | N/A |
| Other current assets | 1,076 | 0 | 0 |
| TOTAL | $76,398 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 24,370 | N/A | N/A |
| Other Non-Current Assets | 663 | 0 | 0 |
| TOTAL | $25,033 | $N/A | $N/A |
| Total Assets | $101,431 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,261 | 0 | 0 |
| Accrued Expenses | 4,879 | N/A | N/A |
| TOTAL | $6,684 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 12,418 | N/A | N/A |
| Other Non-Current Liabilities | 3,207 | 0 | 0 |
| TOTAL | $17,903 | $N/A | $N/A |
| Total Liabilities | $24,587 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -126,595 | N/A | N/A |
| Other shareholders' equity | 201,109 | 0 | 0 |
| TOTAL | $76,844 | $N/A | $N/A |
| Total Liabilities And Equity | $101,431 | $0 | $0 |